A previous study of cervical squamous cell carcinoma (CSCC) suggested that BRCA1 overexpression may have been associated with resistance to concurrent chemoradiotherapy (CCRT) in a subset of patients [30]. The gene discussed is BRCA1; the disease is cervical squamous cell carcinoma.